235 related articles for article (PubMed ID: 17129388)
1. Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis.
Giamarellos-Bourboulis EJ; Tsaganos T; Spyridaki E; Mouktaroudi M; Plachouras D; Vaki I; Karagianni V; Antonopoulou A; Veloni V; Giamarellou H
Crit Care; 2006; 10(6):R166. PubMed ID: 17129388
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K
J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631
[TBL] [Abstract][Full Text] [Related]
3. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock?
Routsi C; Giamarellos-Bourboulis EJ; Antonopoulou A; Kollias S; Siasiakou S; Koronaios A; Zakynthinos S; Armaganidis A; Giamarellou H; Roussos C
Clin Exp Immunol; 2005 Oct; 142(1):62-7. PubMed ID: 16178857
[TBL] [Abstract][Full Text] [Related]
4. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression.
Dimopoulou I; Pelekanou A; Mavrou I; Savva A; Tzanela M; Kotsaki A; Kardara M; Orfanos SE; Kotanidou A; Giamarellos-Bourboulis EJ
J Crit Care; 2012 Jun; 27(3):294-300. PubMed ID: 21855288
[TBL] [Abstract][Full Text] [Related]
5. Monocytes as a site of production of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in the septic host.
Plachouras D; Routsi C; Giamarellos-Bourboulis EJ; Spyridaki E; Andrianakis I; Metzelopoulos S; Tsaganos T; Floros I; Douzinas EE; Armaganidis A; Roussos C; Giamarellou H
Scand J Infect Dis; 2006; 38(10):909-15. PubMed ID: 17008237
[TBL] [Abstract][Full Text] [Related]
6. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation.
Bopp C; Hofer S; Bouchon A; Zimmermann JB; Martin E; Weigand MA
Eur J Anaesthesiol; 2009 Jun; 26(6):504-7. PubMed ID: 19307971
[TBL] [Abstract][Full Text] [Related]
7. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis.
Adly AA; Ismail EA; Andrawes NG; El-Saadany MA
Cytokine; 2014 Feb; 65(2):184-91. PubMed ID: 24290866
[TBL] [Abstract][Full Text] [Related]
8. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis.
Chen CH; Liao HT; Chen HA; Liang TH; Wang CT; Chou CT
J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145
[TBL] [Abstract][Full Text] [Related]
9. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women.
Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H
Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
[TBL] [Abstract][Full Text] [Related]
11. [Immunologically-competent cells in liver infiltrating lymphocytes in patients with chronic severe hepatitis B].
Zou ZS; Xu DP; Li BS; Huang L; Fu JL; Zhang Z; Jin L; Liu QF; Zhang H; Xin SJ; Wang FS
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2416-9. PubMed ID: 18036321
[TBL] [Abstract][Full Text] [Related]
12. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis.
Barati M; Bashar FR; Shahrami R; Zadeh MH; Taher MT; Nojomi M
J Crit Care; 2010 Jun; 25(2):362.e1-6. PubMed ID: 19914031
[TBL] [Abstract][Full Text] [Related]
13. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease.
Rohde G; Radsak MP; Borg I; Buhl R; Schultze-Werninghaus G; Taube C
Respiration; 2012; 83(2):133-9. PubMed ID: 21701149
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis.
Yasuda T; Takeyama Y; Ueda T; Shinzeki M; Sawa H; Takahiro N; Kamei K; Ku Y; Kuroda Y; Ohyanagi H
Crit Care Med; 2008 Jul; 36(7):2048-53. PubMed ID: 18552693
[TBL] [Abstract][Full Text] [Related]
16. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
17. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
[TBL] [Abstract][Full Text] [Related]
19. Serum of patients with septic shock stimulates the expression of Trem-1 on U937 monocytes.
Dimopoulou I; Orfanos SE; Pelekanou A; Kotanidou A; Livaditi O; Augustatou C; Zervou M; Douka E; Theodorakopoulou M; Karagianni V; Douzinas E; Armaganidis A; Giamarellos-Bourboulis EJ
Inflamm Res; 2009 Mar; 58(3):127-32. PubMed ID: 19109693
[TBL] [Abstract][Full Text] [Related]
20. sTREM-1 is a potential useful biomarker for exclusion of ongoing infection in patients with secondary peritonitis.
Determann RM; van Till JW; van Ruler O; van Veen SQ; Schultz MJ; Boermeester MA
Cytokine; 2009 Apr; 46(1):36-42. PubMed ID: 19251433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
